To shed pounds fast, Indians are going to great lengths to secure weight-loss drugs from abroad. Soon, they may not have to look elsewhere as US drugmaker Eli Lilly gets early approvals in India for its new weight-loss drug.
We rarely make our stories free to read. This one is, so make the most of it.
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
No payment details required
Limited time offer $125 $99 for 1 year
Bluesky vs X, the UAE deluge, Adar Poonawalla’s investment in Karan Johar’s Dharma Productions and more.
The food and grocery delivery company’s idea of providing prescription drugs in 10 minutes is facing resistance from traditional pharma players.
A gung-ho attitude to the market hinges on rate cut expectations, but the risk of tapering earnings growth spoiling the party is a very real prospect.